Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Jul 19;293(6540):161–162. doi: 10.1136/bmj.293.6540.161

Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis.

M Goldman, C Liesnard, J L Vanherweghem, N Dolle, C Toussaint, S Sprecher, J Cogniaux, L Thiry
PMCID: PMC1340904  PMID: 3089438

Abstract

Patients and members of staff from a haemodialysis unit were tested for markers of infection with human T cell lymphotropic virus type III (HTLV-III), the virus associated with the acquired immune deficiency syndrome (AIDS). An enzyme linked immunosorbent assay showed eight of 100 patients to have antibodies to HTLV-III. In five of these patients past or present infection with HTLV-III was confirmed by Western blot analysis or detection of HTLV-III antigens in lymphocyte cultures, or both. Investigation of other risk factors for AIDS showed that the putative source of HTLV-III was unrelated to dialysis in two patients whereas blood transfusion was the most likely cause of contamination in the others. No member of staff gave a positive result in the enzyme linked immunosorbent assay. Nosocomial transmission of HTLV-III seems unlikely if precautions similar to those recommended for the control of hepatitis B infection are applied.

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eyster M. E., Goedert J. J., Sarngadharan M. G., Weiss S. H., Gallo R. C., Blattner W. A. Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA. 1985 Apr 19;253(15):2219–2223. [PubMed] [Google Scholar]
  2. Favero M. S. Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis. Infect Control. 1985 Aug;6(8):301–305. doi: 10.1017/s0195941700063141. [DOI] [PubMed] [Google Scholar]
  3. Feorino P. M., Jaffe H. W., Palmer E., Peterman T. A., Francis D. P., Kalyanaraman V. S., Weinstein R. A., Stoneburner R. L., Alexander W. J., Raevsky C. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med. 1985 May 16;312(20):1293–1296. doi: 10.1056/NEJM198505163122005. [DOI] [PubMed] [Google Scholar]
  4. Neumayer H. H., Wagner K., Kresse S. HTLV-III antibodies in patients with kidney transplants or on haemodialysis. Lancet. 1986 Mar 1;1(8479):497–497. doi: 10.1016/s0140-6736(86)92948-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES